Generic Pharmaceuticals Company Investment Opportunity in Mumbai, India
14 years old pharma company approved by EU GMP, Netherlands for formulation, development & manufacturing.
Premium Plan
| Established | 10-20 year(s) |
| Employees | 10 - 50 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 1.09 million |
| Run Rate Sales | USD 2.15 million |
| EBITDA Margin | 30 - 40 % |
| Industries | Generic Pharmaceuticals |
| Locations | Mumbai |
| Local Time | 2:46 PM Asia / Kolkata |
| Listed By | Business Owner / Director |
| Status | Active |
Partial Stake Sale
USD
1.43 million
for
30.0%
stake
(Native Currency: INR 120,000,000)
Reason: For growth working capital requirement and to accelerate expansion plans. We have a wonderful opport...
View More
Includes physical assets worth
USD
1.43 million
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Business Overview
- Business was originally established 14 years ago by a reputed international pharma company.
- We acquired this company and have been operating for 3 years.
- It was a 100% subsidiary of Nordic Group, Netherlands, and export-oriented. The main capabilities are product development and manufacturing plant for pharmaceutical products.
- We provide CRO and CDMO services to manufacturing firms globally.
- We currently have many international clients mainly in the EU, UK, South Africa, Australia, UAE, Philippines, Malaysia, Canada, and many more.
- Current promoters have been in this field for more than 50+ years combined experience.
- Business is approved by EU GMP.
- We have posted 4x growth since last year.
- We acquired this company and have been operating for 3 years.
- It was a 100% subsidiary of Nordic Group, Netherlands, and export-oriented. The main capabilities are product development and manufacturing plant for pharmaceutical products.
- We provide CRO and CDMO services to manufacturing firms globally.
- We currently have many international clients mainly in the EU, UK, South Africa, Australia, UAE, Philippines, Malaysia, Canada, and many more.
- Current promoters have been in this field for more than 50+ years combined experience.
- Business is approved by EU GMP.
- We have posted 4x growth since last year.
Products & Services Overview
Product development, analytical development and stability studies, bio batches packaging and manufacturing, commercial formulation, technology transfer, manufacturing of tablets, pellets, sachets and powder for regulated markets including CDMO and CRO solutions.
Assets Overview
100+ pharma machineries and laboratory equipment, compressors and generators, stock and raw material, 3 intellectual property rights.
Facilities Overview
The facility is a 17,000 sq. ft. unit consisting of 2 floors in Mulund, Mumbai, Maharashtra India.
Capitalization Overview
Funded by promoters, as they have planned earlier to raise additional funds once their strategy shows strategic traction, and since last year the growth is visible and now, we are actively searching for investor.
Recent Activity
-
Earlier than 15 daysDirector, IT Services, Dubai, Corporate Investor / Buyer connected with the Business
-
Earlier than 15 daysCEO, Engineering & Electrical Manufacturing, Mumbai, Corporate Investor / Buyer connected with the Business
-
Earlier than 15 daysOwner, Nashik, Financial Consultant connected with the Business
Tags:
Generic Pharmaceuticals Company Investment Opportunity in Mumbai, India
·Generic Pharmaceuticals Company Investment Opportunity in Bombay
·Invest in Generic Pharmaceuticals Company in Mumbai, India
·Generic Pharmaceuticals Company Investment Opportunity
·Invest in Generic Pharmaceuticals Company in Bombay
·Invest in Generic Pharmaceuticals Company
·Investment Opportunity in Mumbai, India
·Investment Opportunity in Bombay
·Invest in Mumbai, India
·Invest in Bombay
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
1 Investor contacted this Business this month.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 109,500+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses